Approvals/TGA/VELMETIA 50/850 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack

Approved

STANDARD

VELMETIA 50/850 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 12076a8f262d220b
Product Name: VELMETIA 50/850 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack
Artg Id: 220156
Artg Name: VELMETIA 50/850 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2014-11-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-01685-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01686-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

12076a8f262d220b

Type

Standard